SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Carl R. who wrote (1977)12/27/1999 1:58:00 PM
From: DanZ  Respond to of 5582
 
Carl,

The process that a company must go through to call something a drug is different than the process that Gum Tech is going through for Zicam. I'm not familiar with the differences, however. Dr. Howard Epstein can probably answer this better than me.

Dan



To: Carl R. who wrote (1977)12/27/1999 2:08:00 PM
From: PaddyD  Read Replies (1) | Respond to of 5582
 
Incidentally Carl; I conducted a clinical test of 2 people last week (my wife and I). I caught the sniffles and started using Zicam after the 2nd day. Nose stopped running immediately, except in the evening. After another couple days it was cleared up. In the case of my wife, she had success even quicker.

The main problem I see with the product is the method of application. The tube contains a jell like substance. You place the plastic tube in your nose 1/8 inch and squeeze it. It doesn't spray into the nostril. You have to hold the substance in for 5 seconds by pressing against your nose.

But hey! If it stops the cold, this is a MINOR irritant. I guarantee you I will be using it for my future colds as long as it keeps working.



To: Carl R. who wrote (1977)12/27/1999 2:42:00 PM
From: out_of_the_loop  Read Replies (1) | Respond to of 5582
 
Carl:

Once a study is published that is beyond reproach, there will be no need to market Zicam any other way (actually there is no need now - sales are MUCH better than expected).

There is no other market for this than OTC.